SCHEMBL7144784

SCHEMBL7144784

Nc1nc(C(=O)NCC(=O)NC(CC(=O)O)c2ccccc2)cs1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGB3 P05106 4/20 0.48
ITGA2B P08514 3/20 0.48
MMP12 P39900 2/20 0.47
MMP3 P08254 1/20 0.47
MMP9 P14780 1/20 0.47
MMP8 P22894 1/20 0.47
MMP13 P45452 1/20 0.47
ITGAV P06756 2/20 0.43
GPR139 Q6DWJ6 2/20 0.43
SLC6A9 P48067 1/20 0.42
CTSA P10619 4/20 0.42
HDAC1 Q13547 1/20 0.42
HDAC8 Q9BY41 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
LMNA P02545 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
ITGB5 P18084 1/20 0.41
ITGB6 P18564 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7144797 1.00 ITGB3 (0.48) ITGB3ITGA2BMMP12MMP3MMP9
SCHEMBL7144735 0.87 ITGB3 (0.47) ITGB3ITGA2BMMP12MMP3MMP9
Hydrochloric Acid SCHEMBL7140436 0.86 ITGB3 (0.46) ITGB3ITGA2BMMP12MMP3MMP9
SCHEMBL7138642 0.84 ITGB3 (0.47) ITGB3ITGA2BMMP12MMP3MMP9
SCHEMBL7138653 0.84 ITGB3 (0.52) ITGB3ITGA2BMMP12MMP3MMP9
Hydrochloric Acid SCHEMBL7141539 0.83 ITGB3 (0.51) ITGB3ITGA2BMMP12MMP3MMP9
Hydrochloric Acid SCHEMBL7141532 0.83 ITGB3 (0.47) ITGB3ITGA2BMMP12MMP3MMP9
SCHEMBL7136785 0.83 ITGB3 (0.50) ITGB3ITGA2BMMP12MMP3MMP9
SCHEMBL7144243 0.82 MEN1 (0.46) ITGB3ITGA2BMMP12MMP3MMP9
Hydrochloric Acid SCHEMBL7136531 0.82 ITGB3 (0.49) ITGB3ITGA2BMMP12MMP3MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0928790-B1 Thiazole derivatives HOFFMANN LA ROCHE (CH) 2003-03-05 EP disclosed
US-6344562-B1 ANTITUMOR AGENTS HOFFMANN-LA ROCHE INC. 2002-02-05 US disclosed
US-20020010316-A1 Thiazole derivatives ALIG LEO (CH) 2002-01-24 US disclosed
US-6320054-B1 INHIBIT BINDING OF ADHESIVE PROTEINS TO THE SURFACE OF DIFFERENT TYPES F CELL AND ACCORDINGLY INFLUENCE CELL-CELL AND CELL-MATRIX INTERACTIONS. HOFFMAN-LA ROCHE INC. 2001-11-20 US disclosed
US-6100282-A Thiazole derivatives HOFFMAN-LA ROCHE INC. (US) 2000-08-08 US disclosed
EP-0928790-A1 Thiazole derivatives F. HOFFMANN-LA ROCHE AG (CH) 1999-07-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020010316-A1 Thiazole derivatives VCAM1, SOST, TGFB1 ITGB3 7/4885ITGA2B 106/4885MMP12 170/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.